Panavir, vaginal suppositories 0.2mg, 5pcs

Composition

Active ingredient:

panavir (polysaccharides of Solanum tuberosum shoots) 200 mcg;

Auxiliary substances:

polyethylenoxide 1500 (macrogol 1500) — 1.2599 g;

polyethylenoxide 400 — macrogol 400) – 0.1399 g;

Pharmacological action

Panavir is a purified extract of the shoots of the Solanum tuberosum plant; the main Active ingredient is a hexose glycoside consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, and uronic acids.

Panavir is an antiviral and immunomodulatory agent. Increases the body’s non-specific resistance to various infections and promotes the induction of interferons alpha and gamma by blood leukocytes.

In therapeutic doses, the drug is well tolerated.

Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic effects. In preclinical studies on laboratory animals, a negative effect on the reproductive function and development of the fetus was not established.

It has anti-inflammatory properties in experimental models of exudative edema, chronic proliferative inflammation and in the test of pseudoallergic inflammatory response to concanavalin A.

Analgesic effect was shown on models of neurogenic pain and pain caused by the inflammatory process and thermal irritation.

It has an antipyretic effect.

Neuroprotective properties are shown on the model of Parkinsonian syndrome caused by systemic use of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

It has the ability to improve the function of the retina and optic nerve.

It has wound-healing properties in the model of gastric ulcer.

Indications

Genital herpes in women — as part of complex therapy.

Use during pregnancy and lactation

Use with caution during pregnancy. Contraindicated during lactation.

Contraindications

• hypersensitivity to the components of the drug;
• severe kidney and spleen diseases;
• pregnancy;
• lactation;
• children under 18 years of age.

Side effects

In rare cases, allergic reactions are possible.

If any undesirable side effects occur or if other side effects are noticed that are not specified in the instructions, it is necessary to stop the drug use and consult a doctor.

Interaction

Not registered.

How to take, course of use and dosage

Intravaginally.

 Enter in the evening into the vagina, as deep as possible, in the supine position with slightly bent legs, daily for 5 days,1 vaginal suppository.

A second course of treatment is possible after consulting a doctor.

Overdose

No overdose cases have been reported.

The results of preclinical studies indicate low toxicity of the drug.

Special instructions

To prevent urogenital reinfection, simultaneous treatment of sexual partners is necessary.

If there is no effect, the diagnosis should be confirmed.

Product form

vaginal suppositories

Storage conditions

Store in a dry place, protected from light, at a temperature of 2-25 °C

Shelf life

3 years

Active ingredient

Panavir

Conditions of release from pharmacies

By prescription

Dosage form

vaginal suppositories

Description

For women, For adults as prescribed by a doctor, For adults

Indications

Herpes, Cytomegalovirus infection